Skip to main content
  • JasonMock

    COVID-19 Reflections One Year Later

    One year has passed since Governor Cooper declared a state of emergency for North Carolina due to the COVID-19 pandemic, and hospitals and health systems across the state had to pivot to take care of their patients. Jason Mock, MD, PhD, assistant professor of medicine in the division of pulmonary diseases and critical care medicine, reflected on the past year in an ABC-11 news re … Continued

  • william-fischer-experimental-pill-treat-COVID

    Antiviral Pill Could Alter the Fight Against COVID

    The International Business Times reports on the drug molnupiravir, which has shown positive results in preliminary studies by significantly reducing infection of the virus in patients after five days of treatment. William Fischer, MD, associate professor of medicine in the division of pulmonary diseases and critical care medicine, and lead investigator of the study at UNC, said t … Continued

  • william-fischer-experimental-pill-treat-COVID

    Can COVID-19 Be Treated With a Pill?

    William Fischer, MD, associate professor of medicine in the division of pulmonary and critical care medicine, who led UNC trials to determine if Molnupiravir could be a possible treatment for COVID-19, was quoted in a CBS-17 News report about its potential to change the way COVID-19 is treated. “The secondary objective findings in this study, of a quicker decrease in infectious v … Continued

  • basch-rivera

    New Lung Cancer Screening Recommendation Expands Access But May Not Address Inequities

    Calling the U.S. Preventive Services Task Force’s newly released recommendation statement to expand eligibility for annual lung cancer screening with low-dose computed tomography a step forward, researchers say future changes should address equity and implementation issues. In an editorial published in JAMA, M. Patricia Rivera, MD, professor of medicine in the division of pulmona … Continued

  • william-fischer-experimental-pill-treat-COVID

    Ridgeback, Merck Announce Preliminary Data of Potential COVID-19 Therapeutic

    The findings reported on a secondary objective to reduce time to negative test result of infectious SARS-CoV-2 virus in individuals with symptomatic COVID-19. UNC School of Medicine’s William Fischer, MD, is the lead investigator on the study of Molnupiravir, the investigational drug also known as EIDD-2801. Merck and Ridgeback Biotherapeutics announced preliminary results from R … Continued

  • Mazen Al-Qadi

    Al-Qadi Receives CHEST Research Award

    Mazen O. Al-Qadi, assistant professor in pulmonary and critical care medicine has received the Alfred Soffer Research Award for “Respiratory variation in right atrial pressure predicts right ventricular dysfunction in patients with precapillary pulmonary hypertension.” This award is named in honor of Dr. Alfred Soffer, Master Fellow of the College, Editor-in-Chief of the journal … Continued

  • Knowles Comments on Durham-Based Startup and Potential New COVID-19 Treatment

    An NPR Blue Ridge Radio reports that a Durham-based life sciences company received promising test results on a new medical device that could become an in-home treatment for the coronavirus. Michael Knowles, MD, the Michael E. Hatcher Distinguished Professor of Medicine in the division of pulmonary diseases and critical care medicines, commented in a statement distributed by EmitB … Continued

  • shannon-carson

    Deadliest Week for Coronavirus in NC Rolls On reports the number of coronavirus-related deaths in North Carolina continues to spike, and the state on Thursday surpassed 9,000 deaths during the pandemic. Shannon Carson, MD, professor of medicine and chief of the division of pulmonary diseases and critical care medicine, said virus-related deaths are the final metric to spike after infections and hospitalizations. “Af … Continued

  • jain-henderson

    Jain, Henderson Share Updates on Medical Student Education

    To all faculty, fellows and residents: It has been quite the year for all of us as we have all adjusted our schedules to accommodate the influx of Covid-19 patients.  Medical students were briefly off clinical duties but thanks to School of Medicine and Department of Medicine leadership, they were back fairly soon with appropriate PPE.  Many thanks to all of you welcoming them ba … Continued

  • Fellows Match to the Department of Medicine

    While the pandemic made this year particularly challenging for fellowship recruitment efforts and interviews, a series of videos showing each program’s strengths was a creative solution, introducing viewers to faculty and current fellows, with a brief glimpse into what it might be like to join the program. And although it was impossible to replicate the experience of visiting in- … Continued